Favorite  |  Set Home
Products > Others > > BMS303141
Product name : BMS303141
Item : CR1801
Price : 200mg, $750;500mg, $1290; 1g, $1990; 2g, $2995
contact : Send inquiry to: info@acesobio.com
CAS : 943962-47-8
Molecular Weight : 424.3
Formula : C₁₉H₁₅Cl₂NO₄S
Storage : at -20°C
Additional information : We offer significant discount for bulky quantity order,Please ask price and availability of other quantities
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→


Details:
 Chemical Information
M.Wt 424.3 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C19H15Cl2NO4S
CAS No 943962-47-8
Solubility

Soluble to 10 mM in DMSO and to 50 mM in ethanol



Biological Activity of BMS-303141

 

BMS-303141 is a potent ATP-citrate lyase (ACL) inhibitor with IC50 value of 0.13 uM (human recombinant ACL).
IC50 value: 0.13 uM [1]
Target: ATP citrate lyase
in vitro: In HepG2 cells, BMS-303141 showed inhibition of total lipid syntheses with an IC50 of 8 μM. A cell based Alamar Blue cytotoxicity assay was used in parallel to differentiate the effect on the inhibition of lipid synthesis versus potential cytotoxicity. Under identical incubation conditions, BMS-303141 showed no cytotoxicity up to 50 μM, indicating the observed inhibition of lipid synthesis was not a result of compound-induced cytotoxicity [1].
in vivo: In mice, BMS-303141 showed an oral bioavailability of 55% but a relatively short half-life of 2.1 h.20 We therefore decided to dose BMS-303141 admixed in the food to assure greater duration of exposure in subsequent chronic efficacy studies.There were a total of four groups in the study; mice on normal diet and high-fat diet controls, and two treated groups that were supplemented with BMS-303141 in their high-fat diet to an equivalent daily dose of 10 or 100 mg/kg. The study was continued for a total of 34 days. Food consumption and body weight gain were tracked along with weekly assessment of lipid and glucose plasma chemistries [1].

 

[1]. Li JJ, et al. 2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors. Bioorg Med Chem Lett. 2007 Jun 1;17(11):3208-11.
Abstract
A novel series of 2-hydroxy-N-arylbenzenesulfonamides were identified to be ATP-citrate lyase (ACL) inhibitors with compound 9 displaying potent in vitro activity (IC(50)=0.13 microM). Chronic oral dosing of compound 9 in high-fat fed mice lowered plasma cholesterol, triglyceride, and glucose, as well as inhibited weight gain.


Related Products :
PEAQX
PEAQX
Price: 200mg, $950;500mg, $1695; 1g, $2490; 2g, $3590
5S rRNA modificator
5S rRNA modificator
Price: 200mg, $659;500mg, $1150; 1g, $1595; 2g, $2355
(+) Etomoxir sodium salt
(+) Etomoxir sodium salt
Price: 200mg, $1750;500mg, $2690; 1g $3590; 2g, $5190
Nitisinone (SC 0735)
Nitisinone (SC 0735)
Price: 200mg, $459;500mg, $850; 1g $1195; 2g, $1795
Ki 16425
Ki 16425
Price: 200mg, $750;500mg, $1190; 1g $1890; 2g, $2995
Zafirlukast
Zafirlukast
Price: 1g, $490
TH302
TH302
Price: 200mg, $1250;500mg, $2090; 1g, $2995;
Sancycline
Sancycline
Price: 200mg, $750;500mg, $1290; 1g, $1990; 2g, $2995